Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Benzalkonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.54 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.54 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.54 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.54 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 5/20 | 0.96 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.96 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.70 |
| ▸ | RAD52 | P43351 | 2/20 | 0.70 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.70 |
| ▸ | MMP2 | P08253 | 1/20 | 0.70 |
| ▸ | MC4R | P32245 | 1/20 | 0.70 |
| ▸ | MLNR | O43193 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3412849 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Miristalkonium Ion SCHEMBL60915 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Benzododecinium SCHEMBL914 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Cetalkonium SCHEMBL7555808 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Hydrochloric Acid SCHEMBL7638682 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Hydrochloric Acid SCHEMBL2825352 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Hydrochloric Acid SCHEMBL23690 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Hydrochloric Acid SCHEMBL2789719 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Miristalkonium Ion SCHEMBL10681405 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 | |
| Hydrochloric Acid SCHEMBL7638004 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPK1SMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3330 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2308466-B2 | Aqueous pharmaceutical compositions containing borate-polyol complexes | NOVARTIS AG (CH) | 2026-05-20 | — | — | EP | claimed |
| WO-2026087715-A1 | STIMULUS-RESPONSIVE GELABLE LIQUID COMPOSITION COMPRISING VESICLES | NANOMOL TECHNOLOGIES, S.L. (ES) | 2026-04-30 | — | — | WO | claimed |
| EP-4532035-B1 | GRANULES OF CLAY-BASED ANTIMICROBIAL PARTICLES | UNILEVER IP HOLDINGS B V (NL) | 2026-04-08 | — | — | EP | claimed |
| US-12584034-B2 | Coating composition for forming a flexible dielectric coat with high dielectric permittivity | TRIBI Technologies d.o.o. (HR) | 2026-03-24 | — | — | US | claimed |
| EP-4704853-A1 | METHOD OF TREATING OPERATIVE COMPLICATIONS OF CATARACT SURGERY | Formosa Pharmaceuticals, Inc. (TW) | 2026-03-11 | — | — | EP | claimed |
| EP-4532036-B1 | SPHERICAL GRANULES OF CLAY-BASED ANTIMICROBIAL PARTICLES | UNILEVER IP HOLDINGS B V (NL) | 2026-03-04 | — | — | EP | claimed |
| EP-4683991-A1 | CONCENTRATED LIQUID CLEANING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2026-01-28 | — | — | EP | claimed |
| EP-4236932-B1 | DEGRADANT COMPOUND IN A MEDICAMENT | VISUS THERAPEUTICS INC (US) | 2026-01-07 | — | — | EP | claimed |
| EP-4440549-B1 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS CONTAINING A NITRIC OXIDE-RELEASING PHOSPHODIESTERASE 5 INHIBITOR AND METHOD FOR THE PREPARATION THEREOF | NICOX SA (FR) | 2025-11-12 | — | — | EP | claimed |
| US-12466948-B2 | Ultra-fast marine-biodegradable composite film | Singular Solutions Inc. (CA) | 2025-11-11 | — | — | US | claimed |
| US-6616922-B2 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | THE DIAL CORPORATION | 2003-09-09 | — | — | US | claimed |
| EP-0842248-B1 | BLOOMING TYPE, HARD SURFACE CLEANING AND/OR DISINFECTING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2003-05-21 | — | — | EP | claimed |
| US-20030091620-A1 | Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same | FIKSTAD DAVID (US) | 2003-05-15 | — | — | US | claimed |
| US-20030022941-A1 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | Henkel IP & Holding GmbH (DE) | 2003-01-30 | — | — | US | claimed |
| WO-2002076207-A1 | ANTIBACTERIAL COMPOSITIONS | THE DIAL CORPORATION (US) | 2002-10-03 | — | — | WO | claimed |
| EP-1217975-A1 | USING QUATERNARY AMMONIUM SALTS FOR TRANSDERMAL DRUG DELIVERY | Watson Pharmaceuticals, Inc. (US) | 2002-07-03 | — | — | EP | claimed |
| WO-2001017472-A1 | USING QUATERNARY AMMONIUM SALTS FOR TRANSDERMAL DRUG DELIVERY | WATSON PHARMACEUTICALS, INC. (US) | 2001-03-15 | — | — | WO | claimed |
| US-5591708-A | ALPHA-TERPINEOL, NONIONIC SURFACTANT AND SOLVENTS WITH WATER AND QUATERNARY AMMONIUM COMPOUND | RECKITT & COLMAN INC. (US) | 1997-01-07 | — | — | US | claimed |
| EP-0132963-A1 | Quaternary ammonium germicides | A.B.M. CHEMICALS LIMITED (GB) | 1985-02-13 | — | — | EP | claimed |
| US-3992432-A | Phase transfer catalysis of heterogeneous reactions by quaternary salts | CONTINENTAL OIL COMPANY (US) | 1976-11-16 | — | — | US | claimed |